Moolec Science SA (MLEC)
6.93
-0.21
(-2.94%)
USD |
NASDAQ |
Sep 04, 16:00
7.02
+0.09
(+1.30%)
After-Hours: 20:00
Moolec Science Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2024 | 7.897 |
| September 30, 2024 | 3.879 |
| June 30, 2024 | 2.154 |
| March 31, 2024 | 2.092 |
| December 31, 2023 | 1.247 |
| September 30, 2023 | 0.311 |
| June 30, 2023 | 0.2618 |
| March 31, 2023 | 0.0138 |
| September 30, 2022 | 0.0587 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.0066 |
| March 31, 2022 | 0.0056 |
| December 31, 2021 | 0.0009 |
| September 30, 2021 | 0.0009 |
| June 30, 2021 | 0.0009 |
| March 31, 2021 | 0.0009 |
| December 31, 2020 | 23.79 |
| September 30, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Arcadia Biosciences, Inc. | 0.00 |
| Zivo Bioscience, Inc. | -0.1684 |
| PMGC Holdings, Inc. | 0.8507 |
| Cordyceps Sunshine Biotech Holdings Co., Ltd. | -- |
| Archer-Daniels-Midland Co. | 0.3963 |